TraceLink and Advanco partner to simplify serialization line management integration
Partnership to collaborate with industry to reduce risk and ensure optimal compliance for all members of the pharmaceutical supply chain.
TraceLink has partnered with Advanco to support pharmaceutical manufacturers with the integration of line management and enterprise systems when complying with new serialization regulations.
The agreement will see TraceLink resell Advanco’s ARC Suite software, an industry-leading software solution that integrates packaging lines and enterprise serialization repositories. It will allow pharmaceutical and contract manufacturing companies to utilize multiple line management systems, providing purchasing flexibility, while also simplifying integration with the TraceLink Life Sciences Cloud at the enterprise and network level for serialization.
As the leading provider for enterprise and network system Levels 4 and 5, TraceLink will offer the Advanco ARC Suite software to customers looking for a consistent global site server solution that is independent of the Line Management System (LMS).
“Pharmaceutical and contract manufacturers continue to face a number of challenges in synchronizing multiple interconnected packaging levels in order to comply with serialization regulations. TraceLink and Advanco recognized the need to provide a flexible option for the industry to cut down on time-consuming and costly integrations between line management and enterprise systems and efficiently comply with serialization regulations,” said Shabbir Dahod, president and CEO of TraceLink.
“TraceLink is partnering with the industry’s leading companies, such as Advanco, to deliver flexible, scalable solutions, quality implementation services and proven production integrations to its customers. These partnerships supplement our ongoing and active involvement with interoperability standards and industry workgroups such as Open-SCS and GS1, which demonstrate TraceLink’s commitment to working collaboratively with industry to reduce risk and ensure optimal compliance for all members of the pharmaceutical supply chain."
ARC Suite will streamline integration across all LMS solutions and remove any restrictions associated with purchasing from multiple line vendors resulting from implementing a proprietary site server. This simplified, interoperable approach through TraceLink and Advanco will allow manufacturers to leverage any combination of line management solutions, while improving procurement and deployment flexibility.
Olgun Yenersoy, founder and CEO of Advanco added: “TraceLink is the global leader in serialization and track and trace at the enterprise level because its proven Life Sciences Cloud serialization platform enables more than 500 pharmaceutical manufacturers, CMOs, distributors, 3PLs and dispensers to exchange data with over 248,000 supply chain partners. The TraceLink and Advanco integration offers true simplicity in system integration and will help facilitate smoother deployment of serialization solutions for all packaging levels. We look forward to this partnership with TraceLink and working collaboratively to help the industry achieve compliance in the EU, US and other global markets.”
Eric Tjoa, CEO of Tjoapack, commented: “As a customer of both TraceLink and Advanco, we’re able to offer easy integration across all line levels, well ahead of the US and EU deadlines, while continuing to guarantee the highest quality of services for our customer base. The partnership between TraceLink and Advanco gives us increased flexibility, particularly for our customers that need options for leveraging different line management strategies, ranging from a single system to several large line management systems. Seamless integration is a core component to success for serialization and an integral factor for pharmaceutical manufacturers to achieve compliance on time.
“We are thrilled about this partnership and will be discussing the benefits of simplified line-level integration with both companies at our upcoming serialization event on 30 March at Tjoapack headquarters.”
Related News
-
News US BIOSECURE Act passed by US House of Representatives
The controversial act, which has already impacted several foreign companies operating in the US, was passed by the House of Representatives on September 9, 2024. It is now headed for the US Senate before it can be signed into law by President Joe Biden... -
News Pharma Supply Chain People Moves
The latest appointments, promotions, and structural changes across the pharmaceutical supply chain. -
News Drug prices agreed upon as part of the US Inflation Reduction Act
The Inflation Reduction Act brought into constitution by the Biden administation in 2022, which proposed a drug price negotiation between the government and pharmaceutical companies, has reached it's first agreement. -
News BIOSECURE Act continues to loom over Chinese pharma manufacturers
With the US BIOSECURE Act on its way to passing into legislation, Chinese companies are facing declining revenues within the first half of 2024 as US pharmaceutical and healthcare companies pull their businesses from the country. -
News Ophthalmologic drug product Eylea faces biosimilar threats after FDA approvals
Regeneron Pharmaceutical’s blockbuster ophthalmology drug Eylea is facing biosimilar competition as the US FDA approves Biocon’s Yesafili and Samsung Bioepis/Biogen’s Opuviz. -
News ONO Pharmaceutical expands oncology portfolio with acquisition of Deciphera
ONO Pharmaceutical, out of Japan, is in the process of acquiring cancer-therapy maker Deciphera Pharmaceuticals for US$2.4 billion. -
News First offers for pharma from Medicare drug price negotiations
Ten high-cost drugs from various pharma manufacturers are in pricing negotiations in a first-ever for the US Medicare program. President Biden’s administration stated they have responded to the first round of offers. -
News Eli Lilly’s Zepbound makes leaps and bounds in weight-loss drug market
In the last week, Eli Lilly has announced their partnership with Amazon.com’s pharmacy unit to deliver prescriptions of Zepbound. Zepbound has also surpassed Novo Nordisk’s Wegovy for the number of prescriptions for the week of March 8.&nbs...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance